Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Liu, Peng  [Clear All Filters]
2022
Liu P, Xie X-R, Wu H, Li H, Chi J-S, Liu X-M, Luo J, Tang Y, Xu C-X. Conditioned medium of mesenchymal stem cells pretreated with HO promotes intestinal mucosal repair in acute experimental colitis. Sci Rep. 2022;12(1):20772.
Xiong Z, Yang L, Li N, Fu J, Liu P, Sun P, Wei W, Xie X. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clin Transl Med. 2022;12(12):e1133.
Fang L, Mei J, Yao B, Liu J, Liu P, Wang X, Zhou J, Lin Z. Hypoxia facilitates proliferation of smooth muscle cells derived from pluripotent stem cells for vascular tissue engineering. J Tissue Eng Regen Med. 2022.
Liu C, Ding H, Zhu Q, Liu P, Zhu Y, Wang L, Ma Y, Zhang W, Tian S, Zhang X, et al. Induction with MEDA regimen and consolidation with Auto-HSCT for stage IV NKTCL patients: a prospective multicenter study. Int J Cancer. 2022.
Liu P, Xie X-R, Wu H, Li H, Chi J-S, Liu X-M, Luo J, Tang Y, Xu C-X. Mesenchymal Stem Cells Promote Intestinal Mucosal Repair by Positively Regulating the Nrf2/Keap1/ARE Signaling Pathway in Acute Experimental Colitis. Dig Dis Sci. 2022.
Kannappan V, Liu Y, Wang Z, Azar K, Kurusamy S, Kilari RS, Armesilla AL, Morris MR, Najlah M, Liu P, et al. PLGA-nano-encapsulated Disulfiram inhibits hypoxia-induced NFκB, cancer stem cells and targets glioblastoma in vitro and in vivo. Mol Cancer Ther. 2022.

Pages